Ryan W. Harrison

806 total citations
25 papers, 520 citations indexed

About

Ryan W. Harrison is a scholar working on Immunology, Dermatology and Epidemiology. According to data from OpenAlex, Ryan W. Harrison has authored 25 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Dermatology and 6 papers in Epidemiology. Recurrent topics in Ryan W. Harrison's work include Psoriasis: Treatment and Pathogenesis (9 papers), Dermatology and Skin Diseases (6 papers) and Antifungal resistance and susceptibility (3 papers). Ryan W. Harrison is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (9 papers), Dermatology and Skin Diseases (6 papers) and Antifungal resistance and susceptibility (3 papers). Ryan W. Harrison collaborates with scholars based in United States, Canada and Australia. Ryan W. Harrison's co-authors include Taye H. Hamza, Susan F. Assmann, Sherrill J. Slichter, Lynne Uhl, Terry Gernsheimer, Laura S. Phieffer, Anna Schoenbrunner, Benjamin A. Sarac, Jeffrey E. Janis and Carmen E. Quatman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Ryan W. Harrison

24 papers receiving 511 citations

Peers

Ryan W. Harrison
Saloua Ladeb Tunisia
Ülker Koçak Türkiye
Seth J. Rotz United States
Sarah Anand United States
Anem Waheed United States
Sophie Restellini Switzerland
Victor M. Aquino United States
Amrit K. Kamboj United States
Saloua Ladeb Tunisia
Ryan W. Harrison
Citations per year, relative to Ryan W. Harrison Ryan W. Harrison (= 1×) peers Saloua Ladeb

Countries citing papers authored by Ryan W. Harrison

Since Specialization
Citations

This map shows the geographic impact of Ryan W. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan W. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan W. Harrison more than expected).

Fields of papers citing papers by Ryan W. Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan W. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan W. Harrison. The network helps show where Ryan W. Harrison may publish in the future.

Co-authorship network of co-authors of Ryan W. Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan W. Harrison. A scholar is included among the top collaborators of Ryan W. Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan W. Harrison. Ryan W. Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gulliver, Wayne, Kyoungah See, Baojin Zhu, et al.. (2023). Development of Psoriasis Assessment Tools Among Patients in the CorEvitas Psoriasis Registry. PubMed. 8(2). 74–82.
3.
Cross, Raymond K., Jenny Sauk, Ryan W. Harrison, et al.. (2022). Poor Patient-Reported Outcomes and Impaired Work Productivity in Patients With Inflammatory Bowel Disease in Remission. SHILAP Revista de lepidopterología. 1(6). 927–935. 3 indexed citations
4.
Ogdie, Alexis, Ryan W. Harrison, Robert R. McLean, et al.. (2022). Prospective cohort study of psoriatic arthritis risk in patients with psoriasis in a real-world psoriasis registry. Journal of the American Academy of Dermatology. 87(6). 1303–1311. 15 indexed citations
5.
Lockshin, Benjamin, Ryan W. Harrison, Robert R. McLean, et al.. (2022). Outcomes in Ixekizumab Patients Following Exposure to Secukinumab and Other Biologics in the CorEvitas Psoriasis Registry. Dermatology and Therapy. 12(12). 2797–2815. 6 indexed citations
6.
Chen, Yu, Gang Wang, Russel Burge, et al.. (2022). Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry. Dermatology and Therapy. 13(1). 187–206. 4 indexed citations
7.
Cross, Raymond K., April N. Naegeli, Ryan W. Harrison, et al.. (2022). Disease Burden and Patient-Reported Outcomes Among Ulcerative Colitis Patients According to Therapy at Enrollment Into CorEvitas’ Inflammatory Bowel Disease Registry. Crohn s & Colitis 360. 4(3). otac007–otac007. 5 indexed citations
8.
Enos, Clinton, et al.. (2021). Psoriasis Severity, Comorbidities, and Treatment Response Differ among Geographic Regions in the United States. SHILAP Revista de lepidopterología. 1(2). 100025–100025. 8 indexed citations
9.
Lockshin, Benjamin, Angel M. Cronin, Ryan W. Harrison, et al.. (2021). Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry. Dermatologic Therapy. 34(2). e14808–e14808. 30 indexed citations
10.
Sarac, Benjamin A., Anna Schoenbrunner, Jeffrey E. Janis, et al.. (2020). A Review of State Guidelines for Elective Orthopaedic Procedures During the COVID-19 Outbreak. Journal of Bone and Joint Surgery. 102(11). 942–945. 111 indexed citations
11.
Duffin, Kristina Callis, Marc A. Mason, Kenneth B. Gordon, et al.. (2020). Characterization of Patients with Psoriasis in Challenging-to-Treat Body Areas in the Corrona Psoriasis Registry. Dermatology. 237(1). 46–55. 27 indexed citations
12.
Cross, Raymond K., April N. Naegeli, Ryan W. Harrison, et al.. (2020). Su1967 DISEASE BURDEN AND PATIENT-REPORTED OUTCOME MEASURES AMONG ULCERATIVE COLITIS PATIENTS ACCORDING TO THERAPY AT ENROLLMENT INTO THE CORRONA IBD REGISTRY. Gastroenterology. 158(6). S–725. 1 indexed citations
13.
Shahriari, Mona, Ryan W. Harrison, Russel Burge, et al.. (2020). Disease response and patient-reported outcomes among initiators of ixekizumab. Journal of Dermatological Treatment. 33(3). 1538–1546. 6 indexed citations
14.
Mease, Philip J., Neil A. Accortt, Sabrina Rebello, et al.. (2019). Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting. Rheumatology International. 39(9). 1547–1558. 8 indexed citations
15.
Castleberry, Chesney, John L. Jefferies, Ling Shi, et al.. (2018). No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy. JACC Heart Failure. 6(3). 222–230. 16 indexed citations
16.
Price, Thomas H., Jeffrey McCullough, Ronald G. Strauss, et al.. (2018). WBC alloimmunization: effects on the laboratory and clinical endpoints of therapeutic granulocyte transfusions. Transfusion. 58(5). 1280–1288. 7 indexed citations
18.
Price, Thomas H., Jeffrey McCullough, Paul M. Ness, et al.. (2014). A Randomized Controlled Trial on the Efficacy of High-Dose Granulocyte Transfusion Therapy in Neutropenic Patients with Infection. Blood. 124(21). 597–597. 3 indexed citations
19.
Harrison, Ryan W., Robert A. Magnussen, & David C. Flanigan. (2013). Avoiding Complications in Patellofemoral Surgery. Sports Medicine and Arthroscopy Review. 21(2). 121–128. 13 indexed citations
20.
Mullis, Brian, et al.. (2012). Use of Bioabsorbable Pins in Surgical Fixation of Comminuted Periarticular Fractures. Journal of Orthopaedic Trauma. 26(10). 607–610. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026